Highlights from PTCOG 2010

OncoLink reporters provide up-to-date coverage of the Particle Therapy Cooperative Group (PTCOG) 49 Conference at Chiba and Gunma University in NIRS, Japan, May, 17 - 22, 2010.
Clinical Results of Spot-Scanning based Proton Radiotherapy: Experience at the Paul Scherrer Institute since 1996
Construction, Commissioning, and First Treatments at the ProCure Oklahoma City and Chicago Proton Therapy Facilities
Particle Therapy for metastatic liver tumors: evaluation of clinical differences between proton and carbon ion therapies
Proton Beam Therapy Reduced Bone Marrow Suppression Compared with IMRT for Patients with Stage III NSCLC Receiving Concurrent Chemotherapy
Proton Radiotherapy for Cardiac and Pulmonary Vessel Sarcomas
Proton therapy in Pediatric Malignancies: Update of the Orsay Experience
Proton-Based Radiotherapy for Unresectable or Incompletely Resected Osteosarcoma
Reduction of Normal Tissue (NT) Toxicity in Patients with Locally Advanced (LA) NSCLC treated with Concurrent Chemotherapy (ChT) and Proton Beam Therapy (PBT) compared to Intensity Modulated Radiation Therapy (IMRT)
Requirements for Development and Expansion of Particle Therapy
Requirements for the Development and Expansion of Particle Therapy
Systematic Review and Meta-Analysis of Best Available Photon, Proton, and Carbon-Ion Radiotherapy in Various Head and Neck Cancers
The Four-Year Beam Delivery Experience at the M.D. Anderson Cancer Center Proton Therapy Center Houston